Thomas Moreau

916 total citations
19 papers, 441 citations indexed

About

Thomas Moreau is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Thomas Moreau has authored 19 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Hematology. Recurrent topics in Thomas Moreau's work include Pluripotent Stem Cells Research (6 papers), Pancreatic function and diabetes (6 papers) and Platelet Disorders and Treatments (5 papers). Thomas Moreau is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Pancreatic function and diabetes (6 papers) and Platelet Disorders and Treatments (5 papers). Thomas Moreau collaborates with scholars based in United Kingdom, France and United States. Thomas Moreau's co-authors include Christian Chabannon, Victoria L. Mascetti, Roger A. Pedersen, Mariaestela Ortiz, Sasha Mendjan, Daniel Ortmann, Dyah W. Karjosukarso, Pascal Finetti, Daniel Birnbaum and François Bertucci and has published in prestigious journals such as Blood, Biomaterials and Cell stem cell.

In The Last Decade

Thomas Moreau

18 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Moreau United Kingdom 10 240 117 65 61 58 19 441
Louis H. Bookbinder United States 7 253 1.1× 176 1.5× 47 0.7× 62 1.0× 64 1.1× 7 641
Aaron D. DeWard United States 12 351 1.5× 121 1.0× 50 0.8× 87 1.4× 221 3.8× 14 697
Shiva Akbarzadeh Australia 14 230 1.0× 60 0.5× 23 0.4× 30 0.5× 117 2.0× 22 560
Jaeger Davis United States 5 287 1.2× 66 0.6× 21 0.3× 66 1.1× 70 1.2× 5 534
Claire Bouvard France 12 262 1.1× 93 0.8× 33 0.5× 29 0.5× 29 0.5× 17 480
Sun Yung United Kingdom 10 605 2.5× 64 0.5× 51 0.8× 76 1.2× 79 1.4× 10 863
Ashley Woods United States 10 290 1.2× 210 1.8× 48 0.7× 97 1.6× 124 2.1× 17 543
Lauriane Janssen Belgium 10 122 0.5× 85 0.7× 29 0.4× 52 0.9× 117 2.0× 11 446
Karine Zaniolo Canada 15 261 1.1× 90 0.8× 20 0.3× 26 0.4× 34 0.6× 26 643
Jenny Zilberberg United States 15 236 1.0× 194 1.7× 121 1.9× 240 3.9× 52 0.9× 43 694

Countries citing papers authored by Thomas Moreau

Since Specialization
Citations

This map shows the geographic impact of Thomas Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Moreau more than expected).

Fields of papers citing papers by Thomas Moreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Moreau. The network helps show where Thomas Moreau may publish in the future.

Co-authorship network of co-authors of Thomas Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Moreau. A scholar is included among the top collaborators of Thomas Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Moreau. Thomas Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Carnicer‐Lombarte, Alejandro, Amy Jin, Sam Hilton, et al.. (2023). Functional neurological restoration of amputated peripheral nerve using biohybrid regenerative bioelectronics. Science Advances. 9(12). eadd8162–eadd8162. 35 indexed citations
2.
Lawrence, Moyra, Susanne Bornelöv, Thomas Moreau, et al.. (2022). Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells. Science Advances. 8(7). eabj8618–eabj8618. 3 indexed citations
3.
Lawrence, Moyra, Amanda Evans, Thomas Moreau, et al.. (2021). Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP. npj Regenerative Medicine. 6(1). 27–27. 9 indexed citations
4.
Evans, Amanda, Amanda Dalby, Holly R. Foster, et al.. (2021). Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors. Blood Advances. 5(7). 1977–1990. 15 indexed citations
5.
Shepherd, Jennifer H., Daniel J. Howard, Amie K. Waller, et al.. (2018). Structurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purity. Biomaterials. 182. 135–144. 32 indexed citations
6.
Dalby, Amanda, José Ballester‐Beltrán, Annett Mueller, et al.. (2018). Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision. Stem Cell Reports. 11(6). 1462–1478. 13 indexed citations
7.
Moreau, Thomas, Amanda Evans, & Cédric Ghevaert. (2018). Differentiation of Human Pluripotent Stem Cells to Megakaryocytes by Transcription Factor-Driven Forward Programming. Methods in molecular biology. 1812. 155–176. 2 indexed citations
8.
Mendjan, Sasha, Victoria L. Mascetti, Daniel Ortmann, et al.. (2014). NANOG and CDX2 Pattern Distinct Subtypes of Human Mesoderm during Exit from Pluripotency. Cell stem cell. 15(3). 310–325. 123 indexed citations
9.
Moreau, Thomas, Maria Colzani, Meera Arumugam, et al.. (2013). In Vitro Production Of Megakaryocytes and Platelets From Human Induced Pluripotent Cells By GMP Compatible Methods. Blood. 122(21). 2401–2401. 2 indexed citations
10.
Boissonneault, Gilbert A., et al.. (2013). INFECTIOUS DISEASES. JAAPA. 26(1). 13–17. 1 indexed citations
11.
Jacquemier, Jocelyne, Pascal Finetti, Thomas Moreau, et al.. (2009). CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Research. 11(1). R1–R1. 122 indexed citations
12.
Moreau, Thomas, et al.. (2009). Hematopoietic engraftment of XLA bone marrow CD34+ cells in NOG/SCID mice. Cytotherapy. 11(2). 198–205. 2 indexed citations
13.
Tonnelle, Cécile, et al.. (2009). Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation. Molecular Immunology. 46(8-9). 1736–1743. 12 indexed citations
14.
Majed, Bilal, Thomas Moreau, Kamel Senouci, et al.. (2009). Corpulence et pronostic du cancer du sein non métastatique de la femme: résultats d'une étude de cohorte observationnelle française. Bulletin du Cancer. 96(5). 531–541. 6 indexed citations
15.
Moreau, Thomas, Vincent Barlogis, Florence Bardin, et al.. (2008). Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. Gene Therapy. 15(12). 942–952. 18 indexed citations
16.
Moreau, Thomas, Boris Calmels, Vincent Barlogis, et al.. (2007). Potential Application of Gene Therapy to X-Linked Agammaglobulinemia. Current Gene Therapy. 7(4). 284–294. 10 indexed citations
17.
Moreau, Thomas, et al.. (2005). Expression and recombination of the EGFP and EYFP genes in lentiviral vectors carrying two heterologous promoters. Cytotherapy. 7(5). 417–426. 2 indexed citations
18.
Moreau, Thomas, Florence Bardin, Jean Imbert, Christian Chabannon, & Cécile Tonnelle. (2004). Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells. Molecular Therapy. 10(1). 45–56. 31 indexed citations
19.
Darlu, Pierre & Thomas Moreau. (1978). Twin studies of blood ionic content.. PubMed. 24 Pt C. 177–85. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis H. Bookbinder Breakdown of academic impact, for papers by Aaron D. DeWard Breakdown of academic impact, for papers by Shiva Akbarzadeh Breakdown of academic impact, for papers by Jaeger Davis Breakdown of academic impact, for papers by Claire Bouvard Breakdown of academic impact, for papers by Sun Yung Breakdown of academic impact, for papers by Ashley Woods Breakdown of academic impact, for papers by Lauriane Janssen Breakdown of academic impact, for papers by Karine Zaniolo Breakdown of academic impact, for papers by Jenny Zilberberg
Rankless by CCL
2026